TALPHERA, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value
TALPHERA, INC. (TLPH) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value of $700.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-23.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 · last filed 2026-03-23
- TALPHERA, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2023-06-30 was -$400.00K.
- TALPHERA, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2023-03-31 was $1.70M.
- TALPHERA, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2025 was $700.00K, a 65.00% decline from fiscal 2024.
- TALPHERA, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2024 was $2.00M, a 122.22% increase from fiscal 2023.
- TALPHERA, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2023 was $900.00K, a 47.06% decline from fiscal 2022.
- TALPHERA, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2022 was $1.70M.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 12 month |
|---|---|---|---|
| 2025-12-31 | $700.00K 10-K · filed 2026-03-23 | ||
| 2024-12-31 | $2.00M 10-K · filed 2026-03-23 | ||
| 2023-12-31 | $900.00K 10-K · filed 2025-03-31 | ||
| 2023-06-30 | -$400.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $1.30M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $1.70M 10-Q · filed 2023-05-10 | ||
| 2022-12-31 | $1.70M 10-K · filed 2024-03-06 | ||
| 2021-12-31 | $2.40M 8-K · filed 2023-08-01 | ||
| 2020-12-31 | $3.60M 10-K · filed 2022-03-10 | ||
| 2019-12-31 | $4.40M 10-K · filed 2021-03-15 | ||
| 2018-12-31 | $4.90M 10-K · filed 2021-03-15 | ||
| 2017-12-31 | $3.50M 10-K · filed 2020-03-16 | ||
| 2016-12-31 | $3.90M 10-K · filed 2019-03-07 | ||
| 2015-12-31 | $5.40M 10-K · filed 2018-03-09 | ||
| 2014-12-31 | $3.20M 10-K · filed 2017-03-03 | ||
| 2013-12-31 | $1.90M 10-K · filed 2016-03-07 | ||
| 2012-12-31 | $1.30M 10-K · filed 2015-03-13 | ||
| 2011-12-31 | $1.10M 10-K · filed 2014-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |